Leaving BNY Website

 

You are leaving the BNY Mellon's Depositary Receipts' Website.
Linked sites are not under the control of The Bank of New York Mellon Corporation or any of its subsidiaries or affiliates (together, the "Company") and the Company is not responsible for the content of any linked site or any link contained in a linked site. If you choose to link to a website not controlled by the Company, you do so entirely at your own risk and the Company makes no warranties, either express or implied, concerning the content of such site, including the accuracy, completeness, reliability or suitability thereof for any particular purpose, nor does the Company warrant that such site or content is free from any claims of copyright, trademark or other infringement of the rights of third parties or that such site or content is devoid of viruses or other contamination. The Company does not guarantee the authenticity of documents on the Internet. Links to other sites do not imply any endorsement of or responsibility for the opinions, ideas, products, information or services offered at such sites, or any representation regarding the content at such sites. The Company reserves the right to terminate any link at any time.

Do you wish to continue to the linked site on these terms?

Stay On Page
Leave Page

© 2025 The Bank of New York Mellon Corporation

Depositary Receipt business and services are conducted through The Bank of New York Mellon.

BNY - DR Legal Disclaimer
  

To learn more about DRs, please contact DRBrokerSolutions@bny.com.

 

The information and data provided herein are provided for general informational purposes only.  BNY does not warrant or guarantee the accuracy, timeliness or completeness of any such information or data.  BNY does not undertake any obligation to update or amend any information or data, and may change, update or amend any information or data at any time without prior notice.

 

BNY provides no advice, recommendation or endorsement with respect to any company or securities.  No information or data is intended to provide legal, tax, accounting, investment, financial, trading or other advice on any matter, and is not to be used as such.  We expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon any information or data, including market value loss on the sale or purchase of securities or other instruments or obligations.

 

Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.

 

BNY collects fees from DR holders pursuant to the terms and conditions of the DRs and any deposit agreement under which they are issued.  From time to time, BNY may make payments to an issuer to reimburse and/or share revenue from the fees collected from DR holders, or waive fees and expenses to an issuer for services provided, generally related to costs and expenses arising out of establishment and maintenance of the DR program.  BNY may pay a rebate to brokers in connection with unsponsored DR issuances; brokers may or may not disclose or pass back some or all of such rebate to the DR investor.  BNY may also use brokers, dealers or other service providers that are affiliates and that may earn or share fees and commissions.

 

BNY may execute DR foreign currency transactions itself or through its affiliates, or the Custodian or the underlying Company may execute foreign currency transactions and pay US dollars to BNY.  In those instances where it executes DR foreign currency transactions itself or through its affiliates, BNY acts as principal counterparty and not as agent, advisor, broker or fiduciary.  In such cases, BNY  has no obligation to obtain the most favorable exchange rate, makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate. BNY earns and retains revenue on its executed foreign currency transactions based on, among other things, the difference between the rate it assigns to the transaction and the rate that it pays and receives for purchases and sales of currencies when buying or selling foreign currency for its own account.  The methodology used by BNY to determine DR conversion rates is available to registered Owners upon request or can be accessed here.  In those instances where BNY's Custodian executes DR foreign currency transactions, the Custodian has no obligation to obtain the most favorable exchange rate or that the method by which the rate will be determined will be the most favorable rate, and BNY makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate.  In certain instances, BNY may receive dividends and other distributions from an issuer of securities underlying DRs in U.S. dollars rather than in a foreign currency.  In such cases, BNY will not engage in or be responsible for any foreign currency transactions and it makes no representation that the rate obtained by an issuer is a favorable rate and it will not be liable for any direct or indirect losses associated with the rate.

 

BNY is a global investments company dedicated to helping its clients manage and service their financial assets throughout the investment lifecycle.  BNY is the corporate brand of The Bank of New York Mellon Corporation (NYSE: BK).

 

BNY's name, brand and/or trademarks may not be used, copied or reproduced without the prior express written consent of BNY.

 

DEPOSITARY RECEIPTS ARE NOT INSURED BY THE FDIC OR ANY OTHER GOVERNMENT AGENCY, ARE NOT DEPOSITS OR OTHER OBLIGATIONS OF, AND ARE NOT GUARANTEED BY, BNY AND ARE SUBJECT TO INVESTMENT RISKS INCLUDING POSSIBLE LOSS OF PRINCIPAL AMOUNT INVESTED.

 

Please also see "Terms of Use."

ACCEPT

Please enable cookies in your browser if you wish to proceed.

Regulation S Disclaimer

 

Access To This Company Profile Is Restricted To Non-U.S. Persons Outside The United States Within The Meaning Of Regulation S Under The U.S. Securities Act Of 1933, As Amended (The "Securities Act").1

 

This company profile does not constitute an offer to sell or the solicitation of an offer to buy any securities in any jurisdiction or under any circumstances in which such offer or solicitation is unlawful.

 

Each person accessing this company profile, by so doing, will be deemed to have acknowledged that: (1) It is not a U.S. person (within the meaning of Regulation S under the Securities Act) and is located outside the U.S. (within the meaning of Regulation S under the Securities Act); and (2) Any securities described herein (A) have not been and will not be registered under the Securities Act or with any securities regulatory authority of any state or other jurisdiction and (B) may not be offered, sold, pledged or otherwise transferred except to persons outside the U.S. in accordance with Regulation S under the Securities Act pursuant to the terms of such securities.

 

If you agree with and accept the foregoing and the Terms of use governing this site, please select "Accept" below. Otherwise, press "Decline" to return to the previous page.

 

1 As defined in the Securities Act, the term "U.S Person" means: (1) any natural person resident in the United States; (2) any partnership or corporation organized or incorporated under the laws of the United States; (3) any estate of which any executor or administrator is a U.S. person; (4) any trust of which any trustee is a U.S. person; (5) any agency or branch of a foreign entity located in the United States; (6) any non-discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary for the benefit or account of a U.S. person; (7) any discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary organized, incorporated, or (if an individual) resident in the United States; and (8) any partnership or corporation if: (A) organized or incorporated under the laws of any foreign jurisdiction; and (B) formed by a U.S. person principally for the purpose of investing in securities not registered under the Securities Act, unless it is organized or incorporated, and owned, by accredited investors (as defined in Rule 501(a)) who are not natural persons, estates or trusts.

I Accept Decline

© 2024 The Bank of New York Mellon Corporation
Depositary Receipt business and services are conducted through The Bank of New York Mellon.

Back to Daily DR Market Summary

StreetAccount Summary - Asian Market Preview: Nikkei Futures (0.03%), Hang Seng Futures (0.78%), ASX SPI 200 +0.37%, S&P Futures (0.00%)

Jan 29 ,2026

  • Synopsis:

    • Asian markets set for negative start to Friday trade. Futures signaling opening decline in Hong Kong and flat start in Japan. Australia firming in initial trade. US contracts flat afterhours following Thursday's tech underperformance. Australian bonds firming, taking cues from overnight strength in Treasuries. FX markets steady after dollar index pulled back. Commodities volatile with gold and silver pushing back towards earlier highs. Crude adding to gains, reaching four-month high. Bitcoin down to two-month low.

    • Overnight, markets processed volatile tech moves with MSFT experiencing biggest decline since Mar-2020 amid earnings takeaways that focused on underwhelming Azure growth. Commodity volatility the other big story with gold and silver seeing huge intra-day swings before finishing well off best levels. Oil extended surge amid ramp continued ramp in concerns about US military strike on Iran. Dollar unable to sustain post-Bessent rebound amid lingering concern about re-emergence of the debasement trade.

    • ~AAPL~ top line beat estimates and guidance, underpinned by strong iPhone demand amid 38% y/y rebound in China revenue. Q2 revenue guidance also surpassed expectations though CEO Tim Cook flagged iPhone supply constraints due to issues with advanced chip manufacturing and anticipates more significant impact from rising memory prices in Q2. Separately, Apple confirmed it acquired Israeli facial recognition start-up Q.AI though did not disclose purchase price.

    • In economic developments, Tokyo core inflation slowed by more than expected, reflecting energy subsidy impact, In other news news, US government shutdown appears to have averted after Trump and Democrats reached deal to fund agencies while continue negotiating over restrictions on immigration enforcement operations. Trump signed executive order threatening additional tariffs on countries selling oil to Cuba. US-Canada trade tensions in focus after Trump threatened 50% tariff on Canadian aircraft.

  • Pre-open Company News:

    • 002670.CH -- Guosheng Securities guides FY net income attributable CNY210.0-280.0M vs year-ago CNY167.4M

    • 500645.IN -- Deepak Fertilisers & Petrochemicals reports Q3 consolidated EPS INR11.21 vs year-ago INR19.86

    • CJLU.SP -- NetLink NBN Trust reports 9M NPAT SG$65.4M, (12%) vs year-ago SG$74.1M

    • SMMT -- Summit Therapeutics announces U.S. FDA acceptance of BLA seeking approval for ivonescimab in combination with chemotherapy in treatment of patients with EGFRm NSCLC post-TKI therapy

    • 531344.IN -- Container Corp. of India reports Q3 consolidated profit after tax INR3.29B vs StreetAccount INR3.75B

    • 6268.JP -- Nabtesco upgraded to buy from hold at Jefferies (timing uncertain)

    • 600675.CH -- China Enterprise guides FY net income attributable CNY100-150M vs FactSet CNY648.0M [1 est]

    • 544285.IN -- Swiggy reports Q3 consolidated EPS (INR4.36) vs year-ago (INR3.48)

    • 1668.HK -- China South City Holdings proposes preliminary restructuring terms

    • 2650.HK -- Shanghai Zhida Technology Development forms 40:60 JV with Chery Motor to develop NEV smart charging infrastructure

    • 002262.CH -- Jiangsu Nhwa Pharmaceutical initiates Class III recall of rivastigmine hydrogen tartrate capsules

    • 956.HK -- China Suntien Green Energy reports Q4 power generation 4,443GWh, +3.7% y/y

    • 506943.IN -- JB Chemicals & Pharmaceuticals CFO Narayan Saraf resigns due to personal reasons, effective 30-Jan

    • 601118.CH -- China Hainan Rubber Industry Group guides FY net income attributable (CNY110-74M) vs FactSet CNY158.5M [2 est, CNY104-213M]

    • 300223.CH -- Ingenic Semiconductor guides FY net income attributable CNY370.1-403.0M vs FactSet CNY464.0M [1 est]

  • On Deck:

    • Hong Kong:

      • Earnings:

        • Hang Lung Group (10.HK), Hang Lung Properties (101.HK)

    • Japan:

      • Economic:

        • 08:30 JST: Unemployment Rate; consensus 2.6%

        • 08:30 JST: CPI Tokyo Y/Y; consensus

        • 08:50 JST: Industrial Production SA M/M (Preliminary); consensus (0.5%)

        • 08:50 JST: Retail Sales NSA Y/Y (Preliminary); consensus +1.2%

        • 14:00 JST: Housing Starts NSA Y/Y; consensus (1.1%)

      • Earnings:

        • Shionogi & Co. (4507.JP), Daiichi Sankyo (4568.JP), Sanwa Holdings (5929.JP), HOYA Corp (7741.JP), Mitsui O.S.K. Lines (9104.JP), SMS Co. (2175.JP), NS Solutions (2327.JP), ZEON Corp (4205.JP), Sumitomo Pharma (4506.JP), Niterra Co. (5334.JP), Komatsu (6301.JP), Socionext (6526.JP), Lasertec (6920.JP), SCREEN (7735.JP), Sumitomo Mitsui Trust Group (8309.JP), Nomura Holdings (8604.JP), Tokyo Metro (9023.JP), NS United Kaiun Kaisha (9110.JP), ANA HOLDINGS (9202.JP), Mitsubishi Logistics (9301.JP), Shikoku Electric Power (9507.JP), SCSK Corp (9719.JP), Autobacs Seven (9832.JP), Daito Trust Construction (1878.JP), CHUDENKO (1941.JP), Nippon Densetsu Kogyo (1950.JP), Kyudenko (1959.JP), Nisshin Seifun Group (2002.JP), MIXI, Inc. (2121.JP), Nihon M&A Center Holdings (2127.JP), Seria Co. (2782.JP), Toyo Suisan Kaisha (2875.JP), ZOZO Inc (3092.JP), SAKURA Internet (3778.JP), Tokuyama (4043.JP), Sekisui Jushi (4212.JP), Kissei Pharmaceutical (4547.JP), Eiken Chemical (4549.JP), Toei Animation (4816.JP), TOTO Ltd (5332.JP), Nippon Light Metal Holdings (5703.JP), Kyoto Financial Group (5844.JP), LIXIL Corp. (5938.JP), Makino Milling Machine Co. (6135.JP), Amano Corp. (6436.JP), Max Co. (6454.JP), Meidensha (6508.JP), Wacom Co. (6727.JP), EIZO Corp. (6737.JP), Alps Alpine (6770.JP), Maxell (6810.JP), Tokyo Kiraboshi Financial Group (7173.JP), Koito Manufacturing (7276.JP), Daishi Hokuetsu Financial Group (7327.JP), CCI Group (7381.JP), AS ONE (7476.JP), Argo Graphics (7595.JP), Shoei Co Ltd (7839.JP), Nichiha (7943.JP), ITOCHU ENEX (8133.JP), Resona (8308.JP), Sumitomo Mitsui Financial (8316.JP), The 77 Bank (8341.JP), Hokuhoku Financial Group (8377.JP), San-in Godo Bank (8381.JP), The Awa Bank (8388.JP), ACOM Co. (8572.JP), Orient (8585.JP), Tokai Tokyo Financial Holdings (8616.JP), Heiwa Real Estate (8803.JP), Keisei Electric Railway (9009.JP), Hankyu Hanshin Holdings (9042.JP), Sankyu (9065.JP), The Kansai Electric Power (9503.JP), The Chugoku Electric Power (9504.JP), Tohoku Electric Power Co. (9506.JP), Kyushu Electric Power (9508.JP), Hokkaido Electric Power Co. (9509.JP), Electric Power Development (9513.JP), Tokyo Gas (9531.JP), TOHO GAS (9533.JP), transcosmos (9715.JP), NSD Co. (9759.JP), Inaba Denkisangyo (9934.JP), Ohsho Food Service (9936.JP), MISUMI Group (9962.JP)

    • South Korea:

      • Earnings:

        • Hyundai Steel (004020.KS), Samsung Heavy Industries Co. (010140.KS), Hyundai WIA (011210.KS), HYUNDAI ROTEM (064350.KS), Hana Financial (086790.KS), Hyundai Autoever (307950.KS)

    • Australia:

      • Economic:

        • 11:30 AEST: Private Sector Credit M/M; consensus

      • Earnings:

        • 4DMedical (4DX.AU)

    • India:

      • Earnings:

        • Aegis Logistics (500003.IN), Procter & Gamble Hygiene & Health Care (500459.IN), Nestle India (500790.IN), Tata Investment (501301.IN), Blue Dart Express (526612.IN), Ajanta Pharma (532331.IN), JBM Auto (532605.IN), KEC International (532714.IN), Meesho Ltd. (544632.IN), Exide Industries (500086.IN), Steel Authority of India (500113.IN), LIC Housing Finance (500253.IN), Cholamandalam Investment & Finance (511243.IN), Welspun (532144.IN), Jindal Steel (532286.IN), Glenmark Pharmaceuticals (532296.IN), Triveni Engineering & Industries (532356.IN), NTPC Ltd (532555.IN), Power Grid Corp. of India (532898.IN), Brigade Enterprises (532929.IN), The New India Assurance (540769.IN), Aster DM Healthcare (540975.IN), MedPlus Health Services (543427.IN), DOMS Industries (544045.IN)

    • Singapore:

      • Earnings:

        • Keppel DC REIT (AJBU.SP), CDL Hospitality Trusts (J85.SP), Mapletree Pan Asia Commercial Trust (N2IU.SP)

    • Taiwan:

      • Economic:

        • 16:00 TST: GDP NSA Y/Y (Preliminary); consensus +7.2%

  • Market Data:

    • Gold (Apr 26): +$89.60 or +1.67% to $5444.40

    • WTI Crude (Mar 26): +$0.15 or +0.23% to $65.57

    • $-¥: (0.45) or (0.29%) to 152.9710

    • $-KRW: (1.51) or (0.11%) to 1428.8600

    • A$-$: +0.00 or +0.16% to 0.7052

    • $-INR: (0.27) or (0.30%) to 91.7819

    • $-CNY: +0.00 or +0.01% to 6.9474

This information and data is provided for general informational purposes only. The Bank of New York Mellon and our information suppliers do not warrant or guarantee the accuracy, timeliness or completeness of this information or data. We provide no advice nor recommendation or endorsement with respect to any company or securities. We do not undertake any obligation to update or amend this information or data. Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.
Please refer to "Terms Of Use".

DEPOSITARY RECEIPTS:
NOT FDIC, STATE OR FEDERAL AGENCY INSURED
MAY LOSE VALUE
NO BANK, STATE OR FEDERAL AGENCY GUARANTEE